ADC Therapeutics (ADCT) Debt to Equity (2021 - 2026)
ADC Therapeutics' (ADCT) quarterly Debt to Equity came in at -$0.53 in Q1 2026, down 11.91% year-on-year from -$0.61 in Q1 2025, and up 13.95% quarter-over-quarter from -$0.62 in Q4 2025.
ADC Therapeutics (ADCT) Debt to Equity (2021 - 2026) Analysis & Trends
ADC Therapeutics has disclosed Debt to Equity across 6 years of filings, most recently posting -$0.53 for Q1 2026.
- Debt to Equity for Q1 2026 came in at -$0.53, down 11.91% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.53 (down 11.91% YoY), and the FY2025 annual result was -$0.62, down 10.79% from the prior year.
- Debt to Equity came in at -$0.53 for Q1 2026 at ADC Therapeutics, up from -$0.62 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $1.38 in Q4 2022 to a low of -$0.86 in Q2 2024.
- The 5-year median for Debt to Equity is -$0.57 (2025), against an average of -$0.43.
- Across the five-year window, Debt to Equity soared 144.05% in 2022 and plunged 155.05% in 2023, its largest moves.
- ADC Therapeutics' Debt to Equity stood at $1.38 in 2022, then slumped by 155.05% to -$0.76 in 2023, then gained by 26.24% to -$0.56 in 2024, then retreated by 10.79% to -$0.62 in 2025, then advanced by 13.95% to -$0.53 in 2026.
- The last three Debt to Equity figures came in at -$0.53 (Q1 2026), -$0.62 (Q4 2025), and -$0.48 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | ADC Therapeutics | 167.24 Mn | -63.76 Mn | 7.33 Mn | -0.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.53 |
| Dec 31, 2025 | -0.62 |
| Sep 30, 2025 | -0.48 |
| Jun 30, 2025 | -0.57 |
| Mar 31, 2025 | -0.48 |
| Dec 31, 2024 | -0.56 |
| Sep 30, 2024 | -0.66 |
| Jun 30, 2024 | -0.86 |
| Mar 31, 2024 | -0.58 |
| Dec 31, 2023 | -0.76 |
| Dec 31, 2022 | 1.38 |
| Dec 31, 2021 | 0.57 |